News Out of Europe: Reckitt Benckiser Confirms $16.7 Billion Mead Johnson Approach
Here is a round-up of the headlines from Europe.
Here's a round-up of the headlines from Europe.
Reckitt Benckiser (RBGLY) confirmed a $16.7 billion Mead Johnson (MJN) approach. The deal will be financed through combination of cash and debt.
Deutsche Bank (DB) - Get Report posted a $1.72 billion full-year loss. This comes amid fines linked to U.S. mortgage bonds and Russian money laundering.
AstraZeneca (AZN) - Get Report posted stronger-than-expected fourth-quarter earnings, although sales of the blockbuster Crestor drug sales continued to slow.
Shell (RDS.A) () shares gained despite weaker-than-expected fourth-quarter earnings, as the oil giant announced it is making progress in its restructuring.
